Missy Broome

It's Missy!

Cancer Experts At Cancer Treatment Centers of America

Cancer Treatment Centers of America

Cancer Treatment Centers of America was founded in 1988 by Richard J. Stephenson in Zion Illinois.

Cancer Treatment Centers of America Locations

  • Southeastern Regional Medical Center

Atlanta, Georgia

  • Midwestern Regional Medical Center

Chicago, Illinois

  • Eastern Regional Medical Center

Philadelphia, Pennsylvania

  • Western Regional Medical Center

Phoenix, Arizona

  • Southwestern Regional Medical Center

Tulsa, Oklahoma

What is Cancer?

Cancer is a disease in which abnormal cells divide uncontrollably and destroy body tissue.

Common Types of Cancer:

  • Breast Cancer
  • Prostate Cancer
  • Basal Cell Cancer
  • Melanoma
  • Colon Cancer
  • Lung Cancer
  • Leukemia
  • Lymphoma

WebMD and Cancer Treatment Center of America

WebMD is a credible website that provides health information for one to help manage their health and seek support inquires pertaining health matters of concern. WebMD is a partner of Cancer Treatment Center of America providing online information to patients diagnosed with some form of cancer. The content found on WebMD is in reference to diagnosis, treatment, survivorship and caregiver support that Cancer Treatment Center of America provides. One will find WebMD’s website navigation friendly.

Cancer Treatment Center of America

The healthcare provided by Cancer Treatment Center of America is tailored to the needs of each individual cancer patient. Cancer Treatment Center of America uses only state-of-the-art technologies and supportive therapies that pin-point possible cancer-related side effects in the best health treatment that can be provided for each patient based on the type of cancer in need of treatment.

The professional healthcare providers at Cancer Treatment Center of America are highly trained professional Registered Nurses that specialize in cancer patient care, and board certified Oncologist that are specialist and experts in treating various types of cancer.

The professional staff at Cancer Treatment Center of America understands how treating a patient with cancer can put a lot of stress on the patient and family members physically and emotionally. The support of the Cancer Treatment Center of America team starts before during and after the patient’s treatment.

Cancer Treatment Center of America staff Care Managers that are like personal nurses that are available seven days a week. 24 hours a day, 365 days a year aiding the patient and family through the cancer treatment process. One will never feel alone receiving healthcare at Cancer Treatment Center of America, support and comfort are expressed at the entrance of each Cancer Treatment Center of America medical center. His facebook page

Clay Siegall – A Cancer Fighting Giant

Seattle Genetics, Inc. was founded in 1998 and is Washington state’s top biotech company that is the forerunner in creating ADC (antibody-drug conjugate) drugs. The drugs are designed to target antigens that delivers a toxin into cells that causes Hodgkin lymphoma, myeloid leukemia, bladder cancer, urothelial cancers, breast cancer, and other types of cancer cells. The toxins are designed to kill the cancer cells but does not harm surrounding normal tissues, unlike chemo.

The future goal of Seattle Genetics is to ennoble itself from a biotech firm to a national and international pharmaceutical company. Seattle Genetics has 11 drugs containing the cancer killing toxins, four of which are approved by the Food and Drug Administration and are designed for immediate sales in the U.S. and international markets. Seattle Genetics is using its own research skills in oncology to manage all of the rights to new drugs and bring them to world-wide pharma markets.

At the head of these innovative drug concepts is Clay Siegall, a tenacious and avant-guard entrepreneur. He serves as the firms’ Co-founder, CEO, Chairman, and President, of Seattle Genetics. He attended and graduated from the University of Maryland with a B.S. in Zoology and a Ph.D. in Genetics from George Washington University. Mr. Siegall has 20 years of experience in researching cancer and varied therapeutic drug advancements, having worked at major research institutes, including Bristol-Myers Squibb from 1991 to 1995. Clay Siegall desires to elevate Seattle Genetics ability to solely market its new drugs internationally. This effort has begun by Siegall opening an office in Switzerland.

Mr. Siegall has been busy serving scientific boards of many cancer-related foundations and serves as a Director on the Washington Biotechnology and Biomedical Association and the Fred Hutchinsoon Cancer Research Business Alliance. Over the years, he had authored many scientific papers and serves on editorial boards for science journals. He has pending patents and has receive notable awards for his toxin research.

Eric Lefkofsky and His Tempus Role

Eric Lefkofsky is the CEO and founder of Tempus. Under his auspices this technology company has built an operating system to battle cancer.This company through its research allows physicians to personalize the care of their cancer patient.

What Eric Lefkofsky has done is to found a company which is researching ways of treating cancer. Why did he do this? It stemmed from watching a family memberbeing treated for this terrible disease. His goal was to bring new and innovative technology to the doctors who are in the front lines treating these patients.

Tempus analyzes data so that physicians have real time data to treat their patients based on analytic s drawn from other cancer patients. They are trying to build precision oncology.

Tempus has built software that physicians can utilize and obtain information so they can treat their patients better without having to waste all of their time researching answers.

Tempus has created this software to make physicians work easier . This allows the doctor more time with the patient and less time comparing data that may be out there.

Tempus is not the only endeavor where Eric Lefkofsky is involved. He also wrote a book which he called “Accelerated Disruption.” This is explained as how a business “misses the boat “by not realizing that “technology can allow a challenge to come from anywhere.This is what the book states. This book was written by Eric Lefkofsky . In it he expresses that in order to compete and to emerge and grow in the coming years they have to improve their technology. Also he stressed that the right companies need to be chosen to be innovated to learn more: click here.

Eric Lefkofsky is not only the CEO of Tempus but he is a trustee in many other organizations like the Lurie’s Children’s Hospital of Chicago,The Steppenwolf Theatre. Eric Lefkofsky”s philanthropic endeavors reach to wide domains, He even has started a foundation with his wife. It is called the Lefkofsky Family Foundation.

This foundation has under its umbrella many businesses and schools .Under Education the schools that are under this part of the umbrella ,each has a different thing that they bring to the table to enhance a child’ Another facet under this umbrella is human rights. It incorporates such companies as The Human Rights Watch and The Jewish United Fund . Both have human rights in their scope of practice.

The world is a better place for having Eric Lefkofsky in it because he uses his entrepreneurial skills to make a better world. And his later skills have proven to benefit mankind in the best possible way. He founded a company which is working diligently to help rid the world of cancer.

They are doing this by testing patient’s blood and arriving at the conclusion of what genotypes can make a person more prone to getting cancer in their lifetime and what type. Then they place this information on their software and send this information to physicians treating cancer in their patients. Eric Lefkofsky,entreprenuer extraordinaire.

Diet Swap Shows That Junk Food Is Really Bad

Twenty volunteers from the United States and twenty volunteers from West Africa agreed to swap diets for two weeks as nutritionist studied the effects of the diet change in each group. While the nutritionist admit that the sampling size for he group was two small to form a real study, the results that they did find were shocking. The group of Americans that were used to a fast food diet showed improvements in the health in the short two week period. A detailed health examination before and after the diet swap showed that the negative effects of a high fatty diet began to dissipate once the Americans began eating a higher fiber diet. The nutritionist found that the western diet generates more fatty cells in the stomach lining of the Americans, causing many locals including Ivan Ong to reconsider what they eat. This leads to bowel related ailments including colon cancer. This finding was supported by the examination of the West Africans who ate only Western styled food for this period. The studies revealed that the lack of fiber plus the addition of the fatty and acid based food greatly degenerated their health in even a short two week time span.Diet Swap Shows fatty Diets Are Bad

The nutritionist state that while further studies should be completed, it is never too late for a person to change their eating habits. A diet high in fiber reduces a number of life altering ailments. The nutritionist hope to publish the results of their diet swap study soon.

Extra Virgin Olive Oil: A Potential Cancer Killer?

In a study published in the journal, Molecular and Cellular Oncology, researchers have discovered that a certain olive oil compound eradicates a cross section of human cancer cells, without inflicting any devastation on cells that are normal and active. Oleocanthal, is a compound which penetrates the infected cell and intersperses enzymes that facilitates the termination of the cell.

The World Cancer Report, published by the United Nation’s World Health Organization in 2014, indicated that worldwide, 14 million cases of cancer were diagnosed in addition to approximately eight million deaths.

Prior research revealed that oleocanthal was effective in terminating certain cancerous cells, but could not determine the mechanisms that fostered its effectiveness. Lead research of this study, Paul Breslin, of Rutgers University School of Environmental and Biological Sciences, believe that the success of oleocanthal can be attributed to the fact that it focuses on a specific protein contained within the cancer cell, which activates a programed cell termination.

In laboratory trials, oleocanthal was administered to the cancerous cells and observed cell deaths occurring at a rate of 30 to 60 minutes. As Marcio Alaor BMG is aware, programmed cell termination usually occurs in a period of 16 to 24 hours. Breslin speculated on the possibility of other factors contributing to cancerous cells death.

Breslin and his research team suggest that further evaluation is necessary beyond the laboratory to demonstrate the potential of oleocantal in eradicating cancer cells and tumors in animals.

Nanotubes Can Help to Detect and Destroy Cancer Cells

Cancer cells are among the more difficult disease tissues to destroy, once these cells have begun to grow. Surgeries and chemotherapy have long been the more advanced methods of finding and delivering an effective and long term treatment for this disease. Today there are laser devices that are being used to detect and destroy cancer cells before they begin to develop. Haidar Barbouti has heard that a modern microscopic gold tube or nanotube is one of the more promising technological advances in the field of medicine and oncology. More on Barbouti can be found on his Linkedin page.

A microscopic gold tube is inserted into an area of a patient, which has indications of abnormal cancer growth. A small tube is able to locate certain body lesions that may be diagnosed as cancerous. A near infrared light frequency generates heat and, also, makes the human skin areas transparent or easy to examine.

A laser nanotube with different strengths is used to reveal tumors. A higher frequency laser tube is effective in killing any tumorous cells that have been located. The nanotube is able to deliver medicine to the area of the patient’s body that needs further treatment and chemotherapy.

This newer form of medical surgery may allow future surgeons to use only injections and laser blasts to eliminate cancerous skin lesions and abnormal areas of cell growth. Scientists at the University of Leeds have successfully completed initial studies indicating useful applications of the nanotube for imaging and cancer removal.